PRLD

3.2001.69%
AC

Aimee Crombie

Senior VP and Head of Strategic Planning & Operations

Ms. Aimee Crombie, Ph.D. is Senior Vice President & Head of Strategic Planning and Operations of Prelude Therapeutics Incorporated from 2022. Prior to joining Prelude, she was Vice President of Research at Trevena, Inc. where she oversaw drug discovery activities supporting target and hit identification, chemical lead optimization, and drug candidate selection. Aimee has contributed to the discovery of several small molecule including oliceridine. Prior to joining Trevena, Aimee was a Member of the Discovery Medicinal Chemistry group at Pfizer (formerly Wyeth) where she contributed to research programs in a variety of therapeutic areas including oncology, inflammation, neuroscience, cardiovascular, and musculoskeletal diseases. Aimee received her B.S. in Chemistry from the University of Pittsburgh and her Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology.

Positions